Biktarvy (bictegravir, emtricitabine, tenofovir alafenamide) is a medication prescribed for the treatment of HIV-1 infection. Its price can vary significantly based on several factors, including geographic location, insurance coverage, and pharmacy.
How Much Does Biktarvy Cost?
The out-of-pocket cost for Biktarvy can range from a few hundred dollars to over $3,000 per month for those without insurance or with high deductibles. For insured patients, co-pays may be lower, often falling within a range of $0 to $100 per month, depending on their specific insurance plan. Gilead Sciences, the manufacturer of Biktarvy, offers patient assistance programs that can help reduce costs for eligible individuals.
What is the Brand Name for Biktarvy?
Biktarvy is a brand-name medication. It combines three active ingredients: bictegravir, emtricitabine, and tenofovir alafenamide.
When Does Biktarvy Go Off-Patent?
The patent expiration dates for Biktarvy are complex due to multiple patents covering different aspects of the drug and its formulation. Information from DrugPatentWatch.com indicates that exclusivity for Biktarvy may extend into the late 2030s or early 2040s, depending on the specific patent and region.
Are There Generic Versions of Biktarvy?
As of late 2023 and early 2024, there are no FDA-approved generic versions of Biktarvy. The drug is still protected by patents, which prevents generic manufacturers from producing and marketing their own versions.
How Can I Get Financial Assistance for Biktarvy?
Patients may find financial assistance through Gilead Sciences' patient assistance programs, such as the Gilead Advancing Access program. These programs are designed to help eligible individuals afford their medications. Additionally, prescription savings cards and discount programs offered by pharmacies or third-party providers may offer some cost reduction. Consulting with a pharmacist or insurance provider can help identify available assistance options.
How Does Biktarvy Compare to Other HIV Medications?
Biktarvy is a complete, single-tablet regimen that is highly effective in suppressing viral load and is generally well-tolerated. It is often prescribed as a first-line treatment option. Other HIV medications may involve multiple pills per day, different dosing schedules, or have varying side effect profiles and drug interaction considerations.
---
Sources:
1. DrugPatentWatch.com